Skip to content

Clubfoot Tenotomy Trial

A Randomized Comparison of Local Anesthetic Options for Clubfoot Tenotomy: Needle-Free Jet Injection Versus Topical Cream

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04766684
Acronym
ClubTT
Enrollment
107
Registered
2021-02-23
Start date
2021-06-01
Completion date
2024-08-01
Last updated
2026-05-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clubfoot

Keywords

Clubfoot, J-Tip, Jet Injection, Local Anesthesia, Topical Anesthesia, Tenotomy, TAL, Achilles Lengthening, Pain Control

Brief summary

Infants undergoing Ponseti treatment for idiopathic clubfoot often require percutaneous tendoachilles lengthening (TAL) after serial casting. This procedure is frequently performed in the office with a local anesthetic to avoid exposure to general anesthesia in the operating room. Topical anesthetic creams are commonly used to provide local analgesia for this procedure. The cream is applied to the infant's skin around the achilles tendon and requires 30 minutes to provide adequate analgesia, reaching a depth of up to 5 mm at maximum effect. An alternative is a needle-free jet injection system that uses compressed CO2 to push 0.25 ml of lidocaine into the skin, providing local analgesia at the site of administration. This method likewise provides analgesia to the site of application at a depth of 5-8 mm, yet only takes approximately 1-2 minutes to achieve maximum effect. Aim 1: Determine which pain management method, topical anesthetic cream (4% liposomal lidocaine) vs. jet infection of local anesthesia (1% lidocaine), provides the greatest pain relief to infants with clubfoot undergoing an in-office percutaneous TAL. Hypothesis: Jet injection will provide equal or greater pain control when compared topical anesthetic cream. Aim 2: Determine if there is a difference in the rate of adverse events between the two pain management methods, topical anesthetic cream (4% liposomal lidocaine) vs. jet infection of local anesthesia (1% lidocaine). Hypothesis: Jet injection of local anesthesia will not be associated with an increased rate of adverse events in comparison to topical anesthetic cream. If jet injection of local anesthesia is shown to provide comparable or better pain control without an increase in adverse events, use of this needle-free injection system will decrease the overall length of the procedure visit, thus increasing quality, safety, and value.

Detailed description

Clubfoot is a common congenital birth deformity, with a prevalence of approximately 1 in 1000 live births. Without treatment, clubfoot can cause significant disability. Percutaneous tendoachilles lengthening (TAL) is commonly required to correct residual equinus deformity during the Ponseti method. TAL may be performed in the operating room under general anesthesia or in outpatient settings using local anesthesia, but evidence guiding optimal anesthetic strategies for in office procedures remains limited. Effective pain control in infancy is critical. Experimental and clinical studies demonstrate that repeated early life painful stimuli lead to hyperinnervation, heightened sensitivity, altered stress responses, and lower pain thresholds later in life. Cumulative procedural pain is associated with poorer cognitive and developmental outcomes and early interventions to reduce pain lessen cortisol exposure and improve neurobehavioral trajectories. Poorly controlled pain during neonatal or early childhood procedures has also been linked to altered pain behaviors during later procedures, emphasizing the long lasting impact of early nociceptive experiences. Existing approaches for in office TAL include needle infiltration of local anesthetic or application of topical anesthetic cream. Needle infiltration may create soft tissue swelling that obscures the tenotomy site and increases procedural difficulty, and both techniques have been associated with substantial infant distress despite adequate application. Needle free jet injection offers a potential alternative. Prior studies demonstrate that jet injection produces less pain than conventional needle infiltration and provides superior analgesia to topical anesthetics for procedures such as venipuncture, intravenous catheter placement, and lumbar puncture. The Clubfoot Tenotomy Trial (ClubTT) was designed to evaluate whether jet injected local anesthesia provides equivalent analgesic efficacy without increasing adverse events compared with topical anesthesia for infants with idiopathic clubfoot undergoing in office TAL.

Interventions

DEVICEJet injection of 1% lidocaine

Jet injection of 1% lidocaine

DRUG4% liposomal lidocaine cream

4% liposomal lidocaine cream

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

On the day of or after the final casting visit, the participant will be randomized in equal proportion (1:1) to either the control group (4% liposomal lidocaine cream with saline jet injection) or the intervention group (placebo cream with 1% lidocaine jet injection). Participants, care providers, investigators, and outcome assessors will be blinded to the randomization groups. An outside pharmacy, the Health & Wellness Compounding Pharmacy, will provide and blind the 4% liposomal lidocaine and placebo creams. The Vanderbilt Investigational Drug Service will provide the blinded 1% lidocaine and saline vials for jet injection. The Investigational Drug Service will store the creams provided by the outside pharmacy and the jet injection vials. They will assist in dispensing the creams/vials to the outpatient clinic.

Eligibility

Sex/Gender
ALL
Age
No minimum to 6 Weeks
Healthy volunteers
No

Inclusion criteria

* Clubfoot patients less than 6 weeks of age at start of casting * Patients requiring in-office percutaneous achilles lengthening (TAL) following serial casting

Exclusion criteria

* Clubfoot patients greater than 6 weeks of age at the start of casting * Previous clubfoot treatment * Patients with a neuromuscular condition (spina bifida, caudal regression syndrome, arthrogryposis, etc.) * In-office TAL is not recommended by treating physician

Design outcomes

Primary

MeasureTime frameDescription
FLACC (Face, Legs, Activity, Cry, Consolability) ScaleFLACC Score at the time of tenotomy (poke of the scalpel)The FLACC scale is used to assess pain in children. For this study, it will be administered by the Certified Child Life Specialist. The Face, Legs, Activity, Cry, Consolability (FLACC) scale is a measurement used to assess pain in children between the ages of 2 months and 7 years or individuals that are unable to communicate their pain. The scale is scored in a range of 0-10 with 0 representing no pain. Lower values represent reduced pain on the scale
Heart RateHeart Rate at the time of tenotomy (poke of the scalpel)Heart Rate
Oxygen SaturationOxygen saturation at the time of tenotomy (poke of the scalpel)Pulse oximetry will be used to measure oxygen levels in the blood. An oxygen saturation level of 95 percent is considered normal

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORJeffrey Martus, MD

Vanderbilt University Medical Center

Participant flow

Recruitment details

Each site screened consecutive patients with presenting with foot deformity to the outpatient clinic. Infants with unilateral or bilateral idiopathic clubfoot aged 6 weeks or less were recruited to enroll in the study. Patients were excluded if there was previous clubfoot treatment, an underlying neuromuscular diagnosis such as spina bifida, or age greater than 6 weeks at the time of enrollment.

Pre-assignment details

Patients enrolled in the study were treated with the Ponseti method. Weekly serial casting was initiated with above-knee Ponseti clubfoot casts. After the final weekly serial casting visit, the attending surgeon determined if the patient would need either unilateral or bilateral TAL due to residual equinus deformity. If tenotomy was not required, the patient was then transitioned to a foot abduction orthosis and removed from the study.

Baseline characteristics

Characteristic
Age, Categorical
<=18 years
94 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
10 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
33 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
5 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
19 Participants
Race (NIH/OMB)
White
67 Participants
Sex: Female, Male
Female
16 Participants
Sex: Female, Male
Male
29 Participants
Unilateral vs. Bilateral Clubfoot Deformity
Bilateral
20 Participants
Unilateral vs. Bilateral Clubfoot Deformity
Unilateral
48 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 490 / 45
other
Total, other adverse events
0 / 490 / 45
serious
Total, serious adverse events
0 / 490 / 45

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 6, 2026